Drugs & Targets FDA approves label update to accelerate thaw time for Adstiladrin gene therapy for NMIBC March 27, 2026Vol.52 No.12
NCI Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccinesNCI Director Letai: “How aggressive can we be?” March 20, 2026Vol.52 No.11By Claire Marie Porter
NCI A new working group will conduct site visits and advise NCAB and NCI director on cancer center grants March 20, 2026Vol.52 No.11By Paul Goldberg
NCI Letai: “From this point forward, it really is much more like business as usual at the NCI.” March 20, 2026Vol.52 No.11By Jacquelyn Cobb
Cancer Policy The reconstitution of ACIP and changes to CDC’s childhood vaccine schedule were likely illegal, judge rules March 20, 2026Vol.52 No.11By Sara Willa Ernst
Cancer Policy EPA proposes amendments to weaken emission limits on ethylene oxide March 20, 2026Vol.52 No.11By Sara Willa Ernst
Cancer Policy FDA launches consolidated adverse event reporting system March 20, 2026Vol.52 No.11By Claire Marie Porter
Cancer Policy House bill proposes to exempt health care workers from H-1B visa $100,000 fee March 20, 2026Vol.52 No.11By Sara Willa Ernst
